Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B

被引:14
|
作者
Masuyer, Geoffrey [1 ]
Beard, Matthew [2 ]
Cadd, Verity A. [2 ]
Chaddock, John A. [2 ]
Acharya, K. Ravi [1 ]
机构
[1] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
[2] Syntaxin Ltd, Units 4 10, Quadrant, Abingdon OX14 3YS, Oxon, England
基金
英国生物技术与生命科学研究理事会;
关键词
Botulinum neurotoxin; Protein engineering; SNARE; Crystal structure; LIGHT-CHAIN PROTEASE; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; TRANSLOCATION; BINDING; DOMAIN; PURIFICATION; ORGANIZATION; CELLUBREVIN; VAMP-2;
D O I
10.1016/j.jsb.2010.11.010
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Botulinum neurotoxins (BoNTs) cause flaccid paralysis by inhibiting neurotransmission at cholinergic nerve terminals. BoNTs consist of three essential domains for toxicity: the cell binding domain (Hc), the translocation domain (Hn) and the catalytic domain (LC). A functional derivative (LHn) of the parent neurotoxin B composed of Hn and LC domains was recombinantly produced and characterised. LHn/B crystallographic structure at 2.8 angstrom resolution is reported. The catalytic activity of LHn/B towards recombinant human VAMP was analysed by substrate cleavage assay and showed a higher specificity for VAMP-1,-2 compared to VAMP-3. LHn/B also showed measurable activity in living spinal cord neurons. Despite lacking the Hc (cell-targeting) domain, LHn/B retained the capacity to internalize and cleave intracellular VAMP-1 and -2 when added to the cells at high concentration. These activities of the LHn/B fragment demonstrate the utility of engineered botulinum neurotoxin fragments as analytical tools to study the mechanisms of action of BoNT neurotoxins and of SNARE proteins. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:52 / 57
页数:6
相关论文
共 50 条
  • [21] Structures of engineered Clostridium botulinum neurotoxin derivatives
    Masuyer, Geoffrey
    Stancombe, Patrick
    Chaddock, John A.
    Acharya, K. Ravi
    ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS, 2011, 67 : 1466 - 1472
  • [22] The role of Clostridium botulinum: A neurotoxin in clinical dermatology
    Matarasso, SL
    WESTERN JOURNAL OF MEDICINE, 1998, 169 (04): : 226 - 226
  • [23] A novel mechanism for Clostridium botulinum neurotoxin inhibition
    Eswaramoorthy, S
    Kumaran, D
    Swaminathan, S
    BIOCHEMISTRY, 2002, 41 (31) : 9795 - 9802
  • [24] BINDING OF CLOSTRIDIUM-BOTULINUM NEUROTOXIN TO GANGLIOSIDES
    OCHANDA, JO
    SYUTO, B
    OHISHI, I
    NAIKI, M
    KUBO, S
    JOURNAL OF BIOCHEMISTRY, 1986, 100 (01): : 27 - 33
  • [25] Structure of dual receptor binding to botulinum neurotoxin B
    Berntsson, Ronnie P-A
    Peng, Lisheng
    Dong, Min
    Stenmark, Pal
    NATURE COMMUNICATIONS, 2013, 4
  • [26] Analysis of neurotoxin cluster genes in Clostridium botulinum strains producing botulinum neurotoxin serotype A subtypes
    Jacobson, Mark J.
    Lin, Guangyun
    Raphael, Brian
    Andreadis, Joanne
    Johnson, Eric A.
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2008, 74 (09) : 2778 - 2786
  • [27] Comparison of electrochemiluminescence assay and ELISA for the detection of Clostridium botulinum type B neurotoxin
    Guglielmo-Viret, V
    Attrée, O
    Blanco-Gros, V
    Thullier, P
    JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 301 (1-2) : 164 - 172
  • [28] Development of sensitive colorimetric capture elisas for Clostridium botulinum neurotoxin serotypes A and B
    Szílagyi, M
    Rivera, VR
    Neal, D
    Merrill, GA
    Poli, MA
    TOXICON, 2000, 38 (03) : 381 - 389
  • [29] Cloning and characterization of the upstream region of Clostridium botulinum type B neurotoxin gene
    Yang, GH
    Dal Rhee, S
    Jung, HH
    Jhee, OH
    Yang, KH
    BIOCHEMISTRY AND MOLECULAR BIOLOGY INTERNATIONAL, 1998, 45 (02): : 401 - 407
  • [30] Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in Japan
    Kozaki, S
    Kamata, Y
    Nishiki, TI
    Kakinuma, H
    Maruyama, H
    Takahashi, H
    Karasawa, T
    Yamakawa, K
    Nakamura, S
    INFECTION AND IMMUNITY, 1998, 66 (10) : 4811 - 4816